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AbsTrACT
background Evidence from high-income countries shows 
that higher adiposity results in an adverse lipid profile, but 
it is unclear whether this association is similar in Sub-
Saharan African (SSA) populations. This study aimed to 
assess the association between total and central adiposity 
measures and lipid profile in Malawi, exploring differences 
by sex and area of residence (rural/urban).
Methods In this cross-sectional study, data from 12 096 
rural and 12 847 urban Malawian residents were used. 
The associations of body mass index (BMI) and waist to 
hip ratio (WHR) with fasting lipids (total cholesterol (TC), 
low-density lipoprotein-cholesterol (LDL-C), high-density 
lipoprotein-cholesterol (HDL-C) and triglycerides (TG)) were 
assessed by area and sex.
results After adjusting for potential confounders, higher 
BMI and WHR were linearly associated with increased TC, 
LDL-C and TG and reduced HDL-C. BMI was more strongly 
related to fasting lipids than was WHR. The associations 
of adiposity with adverse lipid profile were stronger in 
rural compared with urban residents. For instance, one 
SD increase in BMI was associated with 0.23 mmol/L 
(95% CI 0.19 to 0.26) increase in TC in rural women and 
0.13 mmol/L (95% CI 0.11 to 0.15) in urban women. Sex 
differences in the associations between adiposity and 
lipids were less evident.
Conclusions The consistent associations observed of 
higher adiposity with adverse lipid profiles in men and 
women living in rural and urban areas of Malawi highlight 
the emerging adverse cardio-metabolic epidemic in this 
poor population. Our findings underline the potential utility 
of BMI in estimating cardiovascular risk and highlight the 
need for greater investment to understand the long-term 
health outcomes of obesity and adverse lipid profiles 
and the extent to which lifestyle changes and treatments 
effectively prevent and modify adverse cardio-metabolic 
outcomes.
InTroduCTIon
In Sub-Saharan Africa (SSA) the prevalence 
of overweight/obesity is increasing rapidly1 
in rural and urban populations that are expe-
riencing lifestyle changes (ie, greater seden-
tary behaviour, tobacco smoking, alcohol 
consumption, unhealthy diets and urban-
isation)2–6 and increasing life expectancy 
(due to reductions in child mortality7 and 
adult HIV-related mortality).8 However, the 
extent to which this transition is affecting 
the risk and burden of dyslipidaemia is little 
Key questions
What is already known?
 ► Previous Sub-Saharan African (SSA) studies com-
paring distributions between rural and urban res-
idents found higher levels of adiposity and more 
atherogenic lipid profiles in urban residents.
 ► Evidence from high-income countries shows that 
higher adiposity results in an adverse lipid profile, 
but whether this association is similar in SSA popu-
lations and whether it differs among men and wom-
en from rural and urban areas is unclear.
What are the new findings?
 ► After adjusting for potential confounders, higher body 
mass index (BMI) and waist to hip ratio (WHR) are 
linearly associated with increased total cholesterol 
(TC), low density lipoprotein-cholesterol (LDL-C) and 
triglycerides (TG) and reduced high density lipopro-
tein-cholesterol (HDL-C) in a large SSA population.
 ► BMI is more strongly associated with adverse lipid 
profile than WHR in this population.
 ► Despite the higher BMI and the less favourable lipid 
profile in urban residents, stronger associations be-
tween BMI and TC, LDL-C and TG are observed in 
rural than urban residents.
What do the new findings imply?
 ► The results highlight the emerging adverse car-
dio-metabolic epidemic in poor populations such 
as Malawi in both men and women from rural and 
urban areas.
 ► Our findings underline the need for greater invest-
ment to understand the long-term health outcomes 
of obesity and adverse lipid profiles and the extent 
to which lifestyle changes and treatments effective-
ly prevent and manage adverse cardio-metabolic 
outcomes.
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understood. Although recent Mendelian randomisa-
tion (using genetic variants as instrumental variables) 
and randomised controlled trial evidence challenge the 
role of low levels of high-density lipoprotein-cholesterol 
(HDL-C) in causing coronary heart diseases (CHD), 
high circulating total cholesterol (TC), low-density lipo-
protein-cholesterol (LDL-C) and triglycerides (TG) are 
key causal risk factors for CHD,9 10 and are effectively and 
cost-effectively reduced by statins with clear benefits for 
primary and secondary CHD prevention. In populations 
of white European origin, higher body mass index (BMI), 
waist to hip ratio (WHR) and waist circumference (WC) 
are associated with higher TC, LDL-C and TG.11 In these 
populations, some studies have reported stronger associ-
ations of WHR or WC, than BMI, with CHD.12 13 However, 
in by far the largest study to date which included ~222 000 
adults from 58 cohorts in an individual participant 
meta-analysis, similar magnitudes of association were 
found for BMI, WC and WHR (HR for CHD (95% CI) for 
a 1 SD greater BMI 1.23 (1.17 to 1.29), WC 1.27 (1.20 to 
1.33) and WHR 1.25 (1.19 to 1.31).14 In that study, repro-
ducibility was also shown to be greater for BMI than WHR 
(or WC). Prospective studies of children/adolescents in 
white European populations also find similar magnitudes 
of association between WC, WHR, waist to height ratio 
and BMI with blood pressure, fasting glucose and fasting 
lipids.15 16 Evidence on the association of adiposity and 
lipid profile in black SSA populations is limited. Most 
studies in SSA have been small or focused on HIV-positive 
individuals, and few have collected fasted blood samples 
and examined differences by sex and area of residence 
(urban/rural).17–20
Some evidence suggests that African women are more 
adipose than Europeans,21 yet people of African ancestry 
have also been shown to have a more favourable lipid 
profile.22 In a small cross-sectional study undertaken 
20 years ago in Cameroon, higher BMI was associated 
with higher blood pressure and higher fasting insulin, 
glucose and TG (other lipids were not assayed) in urban 
residents, but with lower blood pressure and lower 
fasting insulin, glucose and TG in rural residents.17 The 
rapid epidemiological transition and the coexistence of 
insults such as infection and malnutrition (including 
undernutrition in early life and emerging overweight 
and obesity in adulthood),23 might influence mani-
festation of adiposity and its association with lipids in 
SSA populations that differ from those in European 
populations and this previous SSA study. For example, 
in Malawi, a very poor SSA country, affected by child-
hood undernutrition and food insecurity, nearly 25% 
of the adult population have raised total cholesterol 
(≥5.0 mmol/L).24
A better understanding of the extent to which the 
adiposity (total and central) associates with lipids in SSA, 
and whether any associations differ by sex and residency 
(urban/rural) is essential to inform the long-term impact 
of obesity and dyslipidaemia on the burden of CHD in 
SSA countries and the development of tools (including 
cardiovascular risk scores) and interventions appropriate 
for the setting.
Our aim was to explore whether there was evidence for 
a causal effect of BMI and WHR on adverse lipid profiles 
in a poor SSA country and whether any effect differed 
between women and men and by rural and urban areas. 
We acknowledge that the data that we are using (popula-
tion representative data from urban and rural Malawi) is 
cross-sectional and likely biased by residual confounding 
(discussed in the limitations of the study). We have care-
fully considered and controlled for observed confounders, 
including several measures of socioeconomic position, 
and believe residual confounding will largely be due to 
reporting bias of behaviours, such as smoking and phys-
ical activity, and our inability to adjust for diet.
MeTHods
study design, setting and participants
The Malawi Epidemiology and Intervention Research 
Unit (MEIRU) collected baseline non-communicable 
disease data, including interviewer-led questionnaires, 
anthropometric and blood pressure measures and a 
fasted blood sample in urban and rural populations 
using a cross-sectional study design between May 2013 
and April 2017. The rural site was in Southern Karonga 
district, where an established Health and Demographic 
Health Surveillance Site is located, and the urban site was 
an enumerated zone in Area 25 of Lilongwe, the capital 
city, in the Central Region. The two study sites have age 
and sex structures comparable to the national rural 
and urban populations and are similar to the national 
average in most socioeconomic, lifestyle and health indi-
cators.25 26 Details on recruitment and data collection 
were previously described.27–29
For this study, we excluded people without serum lipid 
measurements and those who reported not fasting before 
the blood collection.
Recruitment and study information was collected at 
the participant’s household by interviewers and nurses. 
Questionnaires were available in English, Chichewa (the 
main language of the Central Region) and Chitumbuka 
(the main language of the Northern Region), and the 
data were collected using Open Data Kit on Android 
operating system tablets.
data collection and definitions
Serum lipids (TC, LDL-C, HDL-C and TG) were obtained 
from a morning venepuncture sample, after a minimum 
8 hour fast. Non-fasted participants were revisited once 
after a second request to fast overnight. The samples 
were processed on the same day (within an average of 
2.6 hours), and all fasting lipids were assayed using the 
enzymatic method (Beckman Coulter Chemistry Analyser, 
model AU480). The two laboratories (one each in the 
rural and urban centres) participated in external (Thistle 
RSA system) and internal quality controls (exchanging 
samples between sites for repeat testing).29 Interbatch 
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and intrabatch coefficients of variation were less than 3% 
for all lipid measures.
TC, LDL-C and TG were considered high if they 
were ≥5.2 mmol/L, 3.4 mmol/L and 1.7 mmol/L, 
respectively, and HDL-C was considered low if it 
was <1.0 mmol/L.30
Anthropometric measures using standard protocols 
were taken twice, and the mean of the two used in all 
analyses. Participants were asked to remove shoes, outer 
clothing and headdresses. Electronic scales (accuracy of 
100 g) were used to measure weight, portable stadiome-
ters (accuracy of 1 mm) were used for height, and waist 
and hip measurements were taken using a non-stretch 
metallic tape with a narrow blade and a blank lead-in. 
WC was measured on bare skin in the narrowest part of 
the abdomen between the ribs and iliac crest, and hip 
circumference was measured over light clothing at the 
widest part of the buttock.
Potential confounders
We considered ethnicity, household assets score, educa-
tion, marital status, parity, smoking status, alcohol intake, 
physical activity, dietary patterns and intake, lipid-low-
ering medication and HIV/antiretroviral therapy (ART) 
to be confounders based on their known or plausible 
effects on adiposity and lipids. We were able to adjust for 
all of these, except dietary characteristics, as data on diet 
have not been collected in this study.
Ethnicity was assessed in seven groups: Chewa, 
Tumbuka, Ngoni, Yao, Lomwe, Nkhonde and other. 
Household assets score was based on the score of the 
cumulative value (using local costings) of 15 items 
(paraffin lamp, radio, mobile phone, land phone, table 
and chair(s), bed and mattress, bicycle, TV, electric/gas 
cooker, sofa set, oxcart, fridge, motorbike, car, and cow), 
and categorised into quintiles within each area. Educa-
tional level was assessed in seven categories (illiterate, no 
formal education; literate, no formal education; standard 
1–5 years, illiterate; standard 1–5 years, literate; standard 
6–8 years; secondary; and tertiary), which were collapsed 
into five categories: no formal education; standard 1–5 
years; standard 6–8 years; secondary; and tertiary. Marital 
status was assessed as never married, married, widowed or 
divorced/separated. Parity (ie, the number of pregnancies 
a woman has experienced irrespective of the outcome) 
was categorised as 0, 1, 2, 3 or ≥4. Cigarette smoking was 
categorised into never smoker, former smoker (stopped 
more than 6 months ago) and current smoker (smoked 
in the last 6 months). Alcohol intake in the previous 12 
months and its frequency were categorised into: never, 
less than once a month, 1–3 days per month, 1–4 days per 
week and five or more days per week. The International 
Physical Activity Questionnaire was used to measure 
reported number of days and frequency of walking, and 
moderate and vigorous physical activity, during leisure-
time, at work and when commuting. This information 
was used to calculate Metabolic Equivalent of Task values 
and from these, physical activity was categorised into low, 
moderate or high. Use of regular lipid-lowering medica-
tion was only asked about in those who reported having 
a diagnosis of raised cholesterol; it was categorised as: no 
raised cholesterol diagnosis, raised cholesterol diagnosis 
not taking medication and raised cholesterol diagnosis 
taking medication. HIV status was investigated as well as 
the use of ART in those who reported being HIV positive.
statistical analysis
As age distributions vary by sex and area of residence in 
this population, age-standardised adiposity, lipid levels 
and proportions of high (or low HDL-C) lipid levels were 
compared between women and men in rural and urban 
areas. Age standardisation was done by direct standard-
isation using the whole cohort, not separated by sex or 
area. We examined associations between adiposity and 
lipids as continuous measures and as binary measures; 
the binary results were considered additional analyses 
and are presented in online supplementary material.
We used multiple linear regression to examine the 
association of both BMI and WHR with each lipid 
measure, adjusted initially for age and then for poten-
tial confounding by ethnicity, household assets, educa-
tion, marital status, parity, smoking, alcohol, physical 
activity, lipid-lowering medication and HIV/ART status. 
We examined the pattern of association (eg, linear or 
non-linear) by inspecting the graphs of mean lipid levels 
by fifths of BMI and WHR measured in SD units (by sex 
and area), and comparing models using fifths of BMI and 
WHR included as categorical variables to those with them 
treated as a continuous score using a likelihood ratio test. 
In the absence of strong evidence for a non-linear asso-
ciation, our main analysis results are differences in mean 
lipid concentrations (mmol/L) for a 1 SD higher BMI or 
WHR. We accounted for potential clustering (since the 
primary sampling unit was the household, and all adults 
in the household were included) by using robust stan-
dard errors in all regression models.
Multiple logistic regression analyses were used to 
examine the association of both BMI and WHR (SD) with 
each dyslipidaemia, adjusted initially for age and then 
for other potential confounders. The same confounders 
used in the linear regression analyses were used for the 
logistic regressions.
All associations were undertaken in four strata—
women from the rural area, men from the rural area, 
women from the urban area and men from the urban 
area, as rural and urban residents have different lifestyles. 
Evidence for differences by sex or area of residence were 
determined by comparing results across these strata and 
computing statistical tests for interactions between sex 
and each anthropometric measurement and between 
area of residence and each anthropometric measure-
ment. We further explored whether HIV status modi-
fied the association between BMI/WHR and lipids31 by 
computing tests for interactions between HIV status and 
each anthropometric measurement.
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Figure 1 Strengthening the Reporting of Observational Studies in Epidemiology flow chart of the study participants. 
Proportions are calculated based on the total eligible and invited. MEIRU, Malawi Epidemiology; NCD, Non communicable 
diseases and Intervention Research Unit.
The analyses were carried out in the software Stata 
V.15.1.
Patient and public involvement
This is a general population cohort study. A wide range 
of community engagement activities were undertaken 
before starting the study to explain why the study was 
being done and what it would involve. Neither community 
members nor participants were invited to comment on 
the study design, and they were not consulted to develop 
patient relevant outcomes or interpret the results. They 
were not invited to contribute to the writing or editing of 
this document for readability or accuracy.
role of the funding source
The study funders had no role in the study design, collec-
tion, analysis and interpretation of data or report writing. 
The corresponding author had full access to the data and 
the final responsibility to submit for publication.
resulTs
From the 33 177 eligible people aged 18 years and above, 
30 575 (13 903 in rural and 16 672 in urban area) provided 
written informed study consent. Fasting lipid measure-
ments were available for 24 943 individuals (12 096 rural 
and 12 847 urban setting) (figure 1). In general, those 
with missing lipid data were more likely to be men, from 
the urban area, younger, to have lower education, lower 
assets score, lower BMI, and to be unmarried (online 
supplementary tables 1 and 2). Women with missing data 
were also more likely to have lower parity and lower levels 
of physical activity.
Compared with the rural population, urban residents 
were younger, had higher education and median house-
hold assets score, and were more likely to be unmar-
ried and to have lower parity (table 1). Smoking and 
alcohol drinking were predominantly male behaviours, 
and current smoking and a higher frequency of alcohol 
intake was most prevalent among rural men. Most of the 
population reported high levels of physical activity, espe-
cially among women. Fewer than 1% had received a diag-
nosis of high cholesterol, and of those, 85% reported not 
taking any lipid-lowering medication. HIV prevalence of 
those consenting to be tested was 10.6% and it was higher 
in women and rural residents; 90.8% of participants who 
were HIV positive reported being on ART. Among those 
included in the analysis, the percentage with missing data 
for any single variable was between 0% and 6%, except 
for HIV/ART status, which was missing for 18.5%, with 
a higher percentage with missing HIV/ART status in the 
rural area (27.5%) (online supplementary table 3).
BMI was higher in women than men and in urban 
than rural residents, but WHR was higher in men than 
women and in rural residents compared with urban resi-
dents (table 2). All age-standardised lipid means were 
higher in urban than rural participants, with TC, LDL-C 
and HDL-C being higher in women, and TG higher in 
men in both rural and urban settings. Of the total partic-
ipants, 10.8%, 16.4%, 32.9% and 8.9% had high TC, 
high LDL-C, low HDL-C and high TG, respectively, and 
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Table 1 Characteristics of the Malawian population according to area of residence and sex
All n=24 943
(%)
Rural residents Urban residents
Women n=7096
(58.7%)
Men n=5000
(41.3%)
Women n=8563
(66.7%)
Men n=4284
(33.3%)
Age—mean (SD) 35.2 (14.7) 37.6 (15.6) 38.1 (16.5) 32.4 (12.4) 33.2 (14.1)
Ethnicity—N (%) Chewa 4934 (19.8) 180 (2.5) 106 (2.1) 3183 (37.2) 1465 (34.2)
Tumbuka 10 815 (43.4) 5355 (75.5) 3847 (77.0) 1025 (12.0) 588 (13.7)
Ngoni 2746 (11.0) 142 (2.0) 99 (2.0) 1691 (19.8) 814 (19.0)
Yao 1052 (4.2) 18 (0.2) 20 (0.4) 665 (7.7) 349 (8.1)
Lomwe 1810 (7.2) 13 (0.2) 10 (0.2) 1146 (13.4) 641 (15.0)
Nkonde 979 (3.9) 517 (7.3) 267 (5.3) 133 (1.5) 62 (1.5)
Other 2607 (10.5) 871 (12.3) 651 (13.0) 720 (8.4) 365 (8.5)
Education—N (%) No formal 892 (3.6) 376 (5.3) 82 (1.6) 382 (4.4) 52 (1.2)
Standard 1–5 2632 (10.5) 1142 (16.1) 522 (10.4) 779 (9.1) 189 (4.4)
Standard 6–8 8352 (33.5) 3715 (52.3) 2076 (41.5) 1958 (22.9) 603 (14.1)
Secondary 10 722 (43.0) 1794 (25.3) 2177 (43.6) 4315 (50.4) 2436 (56.9)
Tertiary 2345 (9.4) 69 (1.0) 143 (2.9) 1129 (13.2) 1004 (23.4)
Quintiles of household 
assets score—median 
(IQR)
1 41.0 (52.5) 31.5 (31.0) 33.0 (33.0) 70.5 (41.0) 72.5 (39.5)
2 117.5 (131.0) 74.5 (14.0) 74.5 (16.5) 205.5 (46.5) 205.5 (58.5)
3 282.5 (209.5) 115.5 (10.0) 115.5 (10.0) 325.5 (183.5) 325.5 (160.5)
4 520.5 (286.0) 234 (38.5) 234.5 (39.5) 520.5 (35.0) 520.5 (35.0)
5 2405.5 (2058.5) 457.5 (177.2) 459.5 (200.0) 2520.5 (35.0) 2520.5 (35.0)
Marital status—N (%) Never married 5442 (21.8) 508 (7.2) 1134 (22.7) 1777 (20.8) 2023 (47.2)
Married 16 119 (64.7) 4946 (69.8) 3616 (72.5) 5490 (64.1) 2067 (48.3)
Widowed 1563 (6.3) 878 (12.4) 62 (1.2) 561 (6.5) 62 (1.4)
Divorced 1799 (7.2) 752 (10.6) 180 (3.6) 735 (8.6) 132 (3.1)
Number of 
pregnancies*—N (%)
0 2031 (13.0) 469 (6.6) NA 1560 (18.2) NA
1 2181 (13.9) 704 (10.0) NA 1476 (17.3) NA
2 2420 (15.5) 886 (12.5) NA 1534 (17.9) NA
3 2254 (14.4) 937 (13.2) NA 1317 (15.4) NA
4+ 6754 (43.2) 4079 (57.7) NA 2675 (31.2) NA
Smoking status—N (%) Never 23 323 (93.5) 7077 (99.7) 4114 (82.3) 8518 (99.5) 3614 (84.4)
Former 565 (2.3) 8 (0.1) 227 (4.5) 29 (0.3) 301 (7.0)
Current 1055 (4.2) 11 (0.2) 659 (13.2) 16 (0.2) 369 (8.6)
Alcohol intake—N (%) Never 20 540 (82.4) 6854 (96.6) 2906 (58.1) 8036 (93.8) 2744 (64.0)
<1 month 1174 (4.7) 98 (1.4) 477 (9.5) 240 (2.8) 359 (8.4)
1–3 days/month 1520 (6.1) 87 (1.2) 670 (13.4) 202 (2.4) 561 (13.1)
1–4 days/week 1333 (5.3) 49 (0.7) 759 (15.2) 63 (0.7) 462 (10.8)
5+ days/week 376 (1.5) 8 (0.1) 188 (3.8) 22 (0.3) 158 (3.7)
Physical activity 
level†—N (%)
Low 527 (2.1) 100 (1.4) 115 (2.3) 127 (1.5) 185 (4.3)
Moderate 1545 (6.2) 224 (3.2) 529 (10.6) 204 (2.4) 588 (13.7)
High 22 871 (91.7) 6772 (94.4) 4356 (87.1) 8232 (96.1) 3511 (82.0)
Lipid-lowering 
medication—N (%)
No raised cholesterol 24 881 (99.75) 7088 (99.9) 4997 (99.94) 8528 (99.6) 4268 (99.63)
No medication 53 (0.21) 8 (0.1) 2 (0.04) 28 (0.3) 15 (0.35)
Taking medication 9 (0.04) 0 (0.0) 1 (0.02) 7 (0.1) 1 (0.02)
HIV status—N (%) HIV negative 18 739 (89.4) 4729 (87.0) 3325 (89.5) 7203 (89.1) 3551 (93.6)
HIV positive 2217 (10.6) 709 (13.0) 381 (10.5) 883 (10.9) 244 (6.4)
ART status‡—N (%) On ART 1440 (90.8) 482 (94.2) 239 (89.9) 573 (89.4) 139 (86.9)
Not on ART 146 (9.2) 30 (5.8) 27 (10.1) 68 (10.6) 21 (13.1)
*Information available only for women.
†Level of physical activity based on metabolic equivalent (MET).
‡Based on those who reported being HIV positive.
ART, anti-retroviral therapy; NA, not applicable.
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Table 2 Age-adjusted mean of body mass index (BMI), waist to hip ratio (WHR) and serum lipids in rural and urban residents, 
by sex
Women
mean (95% CI)
Men
mean (95% CI) P value
BMI (kg/m2)
  Rural (n=6667)/(n=4990) 23.3 (23.2 to 23.4) 21.6 (21.5 to 21.6)
  Urban (n=8169)/(n=4282) 25.8 (25.7 to 25.9) 22.7 (22.6 to 22.8)
  P value for difference between sex <0.001
  P value for difference between areas <0.001
WHR
  Rural (n=6674)/(n=4990) 0.85 (0.85 to 0.85) 0.86 (0.86 to 0.86)
  Urban (n=8169)/(n=4282) 0.81 (0.81 to 0.81) 0.85 (0.85 to 0.85)
  P value for difference between sex <0.001
  P value for difference between areas <0.001
TC (mmol/L)
  Rural (n=7096)/(n=5000) 4.00 (3.98 to 4.02) 3.73 (3.70 to 3.75)
  Urban (n=8563)/(n=4284) 4.11 (4.08 to 4.13) 3.98 (3.95 to 4.01)
  P value for difference between sex <0.001
  P value for difference between areas <0.001
LDL-C (mmol/L)
  Rural (n=7096)/(n=5000) 2.62 (2.61 to 2.64) 2.39 (2.37 to 2.41)
  Urban (n=8563)/(n=4284) 2.73 (2.71 to 2.75) 2.64 (2.62 to 2.67)
  P value for difference between sex <0.001
  P value for difference between areas <0.001
HDL-C (mmol/L)
  Rural (n=7096)/(n=5000) 1.15 (1.14 to 1.16) 1.09 (1.08 to 1.10)
  Urban (n=8563)/(n=4284) 1.20 (1.19 to 1.21) 1.15 (1.14 to 1.16)
  P value for difference between sex <0.001
  P value for difference between areas <0.001
TG (mmol/L)
  Rural (n=7096)/(n=5000) 0.85 (0.84 to 0.86) 1.02 (1.00 to 1.04)
  Urban (n=8563)/(n=4284) 0.94 (0.93 to 0.95) 1.13 (1.11 to 1.16)
  P value for difference between sex <0.001
  P value for difference between areas <0.001
HDL-C, high density lipoprotein-cholesterol; LDL-C, low density lipoprotein-cholesterol; TC, total cholesterol; TG, triglycerides.
48.9% had any dyslipidaemia, with differences between 
rural and urban and men and women groups reflecting 
the pattern of differences in mean levels of these lipids 
(online supplementary table 4).
There was no strong evidence of departure from 
linear associations between BMI/WHR and the lipids 
in any of the groups (online supplementary figure 1). 
Similar patterns of association between the age-ad-
justed associations (online supplementary figure 2) 
and confounder-adjusted analyses were observed. In 
the confounder-adjusted analyses, there were positive 
associations of BMI and WHR with TC, LDL-C and TG 
and inverse with HDL-C in both men and women in 
rural and urban areas (table 3, in mmol/L; figure 2, in 
SD). The magnitude of the associations, particularly for 
TC and LDL-C, were stronger for BMI than WHR (eg, 
in rural women, 1 SD higher BMI was associated with 
0.23 mmol/L (95% CI 0.19 to 0.26) higher TC, while 1 SD 
higher WHR was associated with 0.06 mmol/L (95% CI 
0.03 to 0.09) higher TC). Associations between BMI and 
serum lipids were mostly similar in magnitude between 
men and women, but the association between BMI and 
TG was stronger in urban men than urban women; 1 SD 
higher BMI was associated with 0.17 mmol/L (95% CI 
0.14 to 0.20) and 0.09 mmol/L (95% CI 0.08 to 0.10) 
higher TG in urban men and women, respectively. Asso-
ciations of BMI with TC, LDL-C and TG were stronger 
in rural than urban women, whereas the associations of 
BMI with HDL-C and of WHR with TC and LDL-C were 
stronger in urban than rural women. In men, area differ-
ences were less evident in the associations between BMI/
WHR and lipids.
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Table 3 Adjusted association between BMI/WHR and serum lipids in Malawian rural and urban women and men
Adjusted difference in outcome per
1 SD higher BMI (95% CI)
Adjusted difference in outcome per
1 SD higher WHR (95% CI)
Difference in mean TC (mmol/L)
  Rural women (n=4971) (n=4975) 0.23 (0.19 to 0.26) 0.06 (0.03 to 0.09)
  Rural men (n=3548) (n=3549) 0.20 (0.16 to 0.23) 0.07 (0.03 to 0.11)
  Urban women (n=7455) 0.13 (0.11 to 0.15) 0.10 (0.07 to 0.12)
  Urban men (n=3705) 0.15 (0.12 to 0.18) 0.08 (0.05 to 0.11)
  P values for difference between sex 0.012 0.442
  P values for difference between area <0.001 0.488
Difference in mean LDL-C (mmol/L)
  Rural women (n=4971) (n=4975) 0.22 (0.19 to 0.24) 0.06 (0.04 to 0.09)
  Rural men (n=3548) (n=3549) 0.18 (0.16 to 0.21) 0.07 (0.04 to 0.11)
  Urban women (n=7455) 0.15 (0.13 to 0.17) 0.10 (0.08 to 0.12)
  Urban men (n=3705) 0.17 (0.14 to 0.19) 0.09 (0.07 to 0.12)
  P values for difference between sex 0.022 0.251
  P values for difference between area 0.001 0.059
Difference in mean HDL-C (mmol/L)
  Rural women (n=4971) (n=4975) −0.03 (−0.04 to −0.02) −0.03 (−0.04 to −0.02)
  Rural men (n=3548) (n=3549) −0.03 (−0.04 to −0.02) −0.03 (−0.05 to −0.02)
  Urban women (n=7455) −0.05 (−0.05 to −0.04) −0.03 (−0.04 to −0.02)
  Urban men (n=3705) −0.04 (−0.05 to −0.04) −0.03 (−0.04 to −0.03)
  P values for difference between sex 0.603 0.730
  P values for difference between area 0.003 0.009
Difference in mean TG (mmol/L)
  Rural women (n=4971) (n=4975) 0.12 (0.10 to 0.13) 0.11 (0.09 to 0.13)
  Rural men (n=3548) (n=3549) 0.16 (0.13 to 0.19) 0.11 (0.08 to 0.14)
  Urban women (n=7455) 0.09 (0.08 to 0.10) 0.09 (0.08 to 0.11)
  Urban men (n=3705) 0.17 (0.14 to 0.20) 0.13 (0.11 to 0.16)
  P values for difference between sex <0.001 0.001
  P values for difference between area 0.039 0.127
Serum lipids were assessed in mmol/L.
Adjusted for age, ethnicity, education, household assets score, marital status, parity (women) use of lipid-lowering medication, smoking status, 
alcohol intake, physical activity and HIV/ART status.
BMI and WHR are used in SD.
ART, antiretroviral therapy; BMI, body mass index; HDL-C, high density lipoprotein-cholesterol; LDL-C, low density lipoprotein-cholesterol; TC, total 
cholesterol; TG, triglycerides; WHR, waist to hip ratio.
Associations with binary levels of each lipid (high TC, 
high LDL-C, low HDL-C and high TG) followed the 
patterns we would expect from the results presented 
here with continuously measured outcomes given asso-
ciations with BMI/WHR with the continuous measures 
were linear (online supplementary table 5 and figure 3).
Overall, the associations between BMI/WHR and 
serum lipids were similar in HIV infected and unin-
fected individuals (online supplementary table 6 and 
figure 4, in mmol/L; in SD). Noticeable differences were 
observed for the association between WHR and TG in 
women, which was stronger in HIV positive than HIV 
negative women. For example, in urban women, 1 SD 
higher WHR was associated with 0.16 mmol/L (95% CI 
0.11 to 0.22) higher TG in those who were HIV positive 
and 0.08 mmol/L (95% CI 0.07 to 0.10) in those who 
were HIV negative women.
dIsCussIon
Our large study in Malawi shows urban residents have a 
less favourable lipid profile than rural residents and that 
in both settings women tended to have less favourable 
profiles than men. After adjusting for several observed 
confounders, we found positive linear associations of 
both BMI and WHR with TC, LDL-C and TG, and an 
inverse association with HDL-C in rural and urban 
Malawian men and women, with little evidence of differ-
ences by sex, but evidence of differences between rural 
and urban residents. Notably, the association between 
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Figure 2 Adjusted association between BMI/WHR and serum lipids in Malawian rural and urban men and women. Adjusted 
for age, ethnicity, education, household assets score, marital status, parity (women), use of lipid-lowering medication, smoking 
status, alcohol intake, physical activity and HIV/ART status. BMI, WHR and serum lipids are used in SD. ART, antiretroviral 
therapy; BMI, body mass index; HDL-C, high density lipoprotein-cholesterol; LDL-C, low density lipoprotein-cholesterol; TC, 
total cholesterol; TG, triglycerides; WHR, waist to hip ratio.
BMI and all serum lipids, except for HDL-C, was stronger 
in rural than urban residents, especially in women. The 
magnitude of the association between adiposity and lipid 
profile was generally stronger for BMI than WHR. This is 
consistent with our earlier findings of a stronger associ-
ations of BMI than WHR with fasting glucose, diabetes, 
systolic and diastolic blood pressure, and hypertension,28 
suggesting that BMI may be a useful predictor of adverse 
cardio-metabolic outcomes in this population.
Studies have been carried out to identify optimal 
threshold of anthropometric measures to predict cardio-
vascular risk in SSA populations and suggested a lower 
threshold for men and similar or higher threshold for 
women than those recommended by the WHO.13 32 Iden-
tifying ideal cut-off points of BMI and WHR for dyslipi-
daemia was out of the scope of this paper. But work to 
validate cardiovascular risk scores by linking to outcomes 
in the region is ongoing. Based on the results presented 
here, we would suggest that prediction models for CVD 
risk may need to be developed separately for rural and 
urban SSA populations.
Other studies carried out in SSA countries, including 
those using WHO STEPS, have also found higher BMI (or 
higher prevalence of obesity)19 33–38 and a more adverse 
lipid profile in women than men.19 20 35 37–39 Despite 
differences in adiposity and lipid profiles between men 
and women, sex differences in the associations between 
BMI/WHR and lipids were less evident. A markedly 
stronger association between BMI and TG in urban men 
than urban women was observed, and further studies to 
assess whether this replicates in other SSA populations 
would be useful.
Higher adiposity and poorer lipid profile in urban 
than rural residents corroborate findings from other 
studies in SSA.34 36 39 40 Although ethnic differences 
between rural and urban residents may play a role, in our 
study results remained unchanged when ethnicity was 
not included in the confounder-adjusted model (results 
available from authors on request), and rapid urbanisa-
tion and its subsequent changes in lifestyle (eg, decrease 
in physical activity, and increase in alcohol intake, access 
to processed food and consumption of unhealthy diets) 
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might explain the more adverse cardio-metabolic profile 
in urban residents compared with those in a rural setting. 
Even though Malawi has a low percentage of the popu-
lation living in urban area (about 16%) and has a lower 
urbanisation rate then other SSA countries, the urban 
population is expected to double by 2050,6 and there-
fore the consequences related to urbanisation might 
become more worrying. A previous study in Uganda has 
shown that even in rural communities, increasing urba-
nicity was associated with higher prevalence of lifestyle 
risk factors for cardio-metabolic diseases, such as lower 
levels of physical activity, higher adiposity and low fruit 
and vegetable consumption.41 Therefore, even small 
increases in urbanisation may have important impli-
cations for the burden of adverse lipid profiles in SSA 
populations.
Stronger associations between BMI and TC, LDL-C and 
TG, and weaker association with HDL-C were found in 
rural than urban residents, and this difference was espe-
cially observed in women. Ours is by far the largest study 
of these associations to date. Of previous SSA studies 
comparing associations of adiposity with lipids between 
rural and urban communities, one from Cameroon 
(n=1628 participants conducted in 1994) has some 
consistency with our findings in that there were positive 
associations of BMI with TG in rural populations, but 
inverse associations in the urban adults and stronger 
positive associations between WC and TG in urban than 
rural participants.17 42 A study in Nigerian (n=247 partic-
ipants, conducted over 15 years ago) found positive asso-
ciations of BMI with TC and TG in urban, but not rural, 
adults.43 By contrast, a Ghanaian study (n=672 partici-
pants conducted in 2013) reported stronger associations 
of WC with TC and LDL-C in rural compared with urban 
adults.40 We have not examined associations of WC with 
lipids in this paper, but we showed in a previous publi-
cation that WC correlated very highly with BMI in the 
MEIRU cohort.28 Thus, this Ghanaian study also has 
some consistency with our findings. Differences between 
studies may be explained by differences in the number 
of participants included, timing in relation to the epide-
miological transition and adjustment for confounding 
factors. However, if the associations of adiposity with 
lipids are stronger in rural areas as our large study and 
some other studies suggest, then with urbanisation of 
these areas the CHD epidemic could be particularly 
marked here.
The prevalence of HIV found in our study is compa-
rable with national estimates,26 and the majority of 
participants who were HIV positive reported being on 
ART. HIV infection and ART are known to be associated 
with cardio-metabolic traits, such as adiposity and lipid 
profile,31 and in our study most associations were similar 
between infected and uninfected participants, but the 
association of WHR and TG in women was particularly 
stronger in HIV positive women. We did not find other 
studies that explored the association between BMI/WHR 
and lipids in HIV-infected and uninfected individuals is 
SSA and this single difference by HIV status could be a 
chance finding.
strengths and limitations
Our study was sufficiently large to explore associations 
by sex and urban and rural locations. The use of fasting 
lipids and of rigorous, standardised protocols and quality 
control procedures for data collection are also strengths 
of our study.
A key limitation of this study is its cross-sectional nature 
which means we cannot assume that the associations 
of adiposity with lipids that we have found are causal. 
Mendelian randomisation studies and result of trials of 
bariatric surgery support causal effects of adiposity on 
HDL-C and TG, though are less clear for LDL-C.9 10 44 We 
adjusted for a wide-range of plausible confounders, but 
misclassification of self-reported lifestyle characteristics, 
such as alcohol consumption and physical activity, might 
mean that we have not fully accounted for these. We did 
not have data on dietary intake and therefore could not 
consider it in the analyses.
The high proportion of missing lipid data in urban 
residents, especially men, might have resulted in some 
selection bias and is likely to have underestimated the 
lipid means and prevalence of dyslipidaemia. The preva-
lence of high TC, LDL-C and TG was considerably lower 
than found in a recent meta-analysis of studies in African 
adults.45 However, our association results would be biased 
if, in those with missing lipid data, associations were 
remarkably different from those with lipid information, 
even after taking into account age, sex, ethnicity, area of 
residence, education, household assets, smoking status, 
alcohol intake, physical activity level and HIV/ART status. 
Although we cannot rule out this possibility, it is unlikely 
to be the case. The much higher level of missing data 
for HIV/ART status in rural compared with urban areas 
might mean that we have greater residual confounding 
by this in rural than urban participants. However, this 
would tend to result in consistently weaker associations 
in rural groups, which is not what we have found.
ConClusIons
In a large, well-conducted study we have shown that higher 
BMI and WHR are associated with adverse lipid profiles 
in men and women in both rural and urban Malawi. 
Associations were stronger for BMI than WHR, and BMI 
may be a more reliable indicator of dyslipidaemia than 
WHR, with greater utility in non-blood based cardio-
vascular risk score development. Our findings illustrate 
some of the nature of the emerging cardio-metabolic 
disease epidemic in Malawi and highlight the need for 
greater investment to understand the longer-term health 
outcomes of obesity and adverse lipid profiles and the 
extent to which lifestyle change and treatments effectively 
prevent and manage adverse cardio-metabolic outcomes 
in rural and urban populations in Malawi and poten-
tially in other SSA populations. Efforts for preventing 
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increases in adiposity in both women and men from 
rural and urban areas should be reinforced in SSA and 
large prospective studies with detailed baseline data, as 
presented here, are fundamental to inform scientific and 
clinical understanding and management of individual 
risk of CHD in this poor population.
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